Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Antigenics Inc. > News item |
Antigenics files $100 million debt, preferred, stock, convertibles shelf
New York, Nov. 27 - Antigenics Inc. filed a $100 million shelf registration covering secured and unsecured debt, preferred stock, depositary shares and common stock with the Securities and Exchange Commission. Debt securities may be convertible into preferred or common stock and the preferred stock may be convertible into common stock.
The New York City-based pharmaceutical company said it would use proceeds for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, clinical trial expenditures, acquisitions of new technologies and investments unless specified otherwise at the time of sale.
End
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.